Cost Effectiveness of IDegLira vs. Alternative Basal Insulin Intensification Therapies in Patients with Type 2 Diabetes Mellitus Uncontrolled on Basal Insulin in a UK Setting

2016 ◽  
Vol 34 (9) ◽  
pp. 953-966 ◽  
Author(s):  
Melanie J. Davies ◽  
Divina Glah ◽  
Barrie Chubb ◽  
Gerasimos Konidaris ◽  
Phil McEwan
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Cost Effectiveness ◽  
Basal Insulin ◽  
Insulin Intensification

scholarly journals Treating Patients with Type 2 Diabetes Mellitus Uncontrolled on Basal Insulin in the Czech Republic: Cost-Effectiveness of IDegLira Versus iGlarLixi

2019 ◽  
Vol 10 (2) ◽  
pp. 493-508 ◽  
Author(s):  
Johannes Pöhlmann ◽  
Monika Russel-Szymczyk ◽  
Pavel Holík ◽  
Karel Rychna ◽  
Barnaby Hunt
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Czech Republic ◽  
Cost Effectiveness ◽  
Basal Insulin ◽  
The Czech Republic

scholarly journals When basal insulin is not enough: successful strategies for insulin intensification in patients with type 2 diabetes mellitus

2017 ◽  
Vol 20 (5) ◽  
pp. 363-373
Author(s):  
Elena V. Buryukova ◽  
Abdul Jabbar ◽  
Svetlana V. Elizarova
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Glycemic Control ◽  
Insulin Therapy ◽  
Clinical Management ◽  
Basal Insulin ◽  
Insulin Intensification ◽  
Advantages And Disadvantages

Maintaining glycemic control through intensive clinical management of patients with type 2 diabetes mellitus (T2DM) is well recognized to reduce the risk of diabetes-associated complications. Patients in Russia have high rates of microvascular and macrovascular complications as a result of undiagnosed, untreated, or inadequately treated diabetes, emphasizing the need for better clinical management. The introduction of basal insulin therapy is often necessary for patients with T2DM when oral antihyperglycemic drugs and lifestyle management strategies are no longer effective inmaintaining glycemic targets. However, after initiation of insulin, patients often remain on basal insulin for long periods despite suboptimal glycemic control, and intensification of insulin therapy is frequently necessary. Here, we report on several different insulin intensification strategies available to clinicians and their patients to improve glycemic control and the advantages and disadvantages of each approach. These strategies include the use of short- and long-acting insulins administered either as bolus doses or as premixed insulins. When selecting the most appropriate intensification strategy, clinicians should consider the lifestyle and treatment goals of their patients to help ensure treatment success.

scholarly journals Cost-Effectiveness of iGlarLixi in People with Type 2 Diabetes Mellitus Suboptimally Controlled on Basal Insulin Plus Metformin in the UK

2021 ◽  
Author(s):  
Rory J. McCrimmon ◽  
Edel Falla ◽  
Jo Zhou Sha ◽  
Abdul Jabbar Omar Alsaleh ◽  
Elisheva Lew ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Cost Effectiveness ◽  
Basal Insulin ◽  
The Uk
Sign in / Sign up

Export Citation Format

Share Document